Ramosetron OD Tablet and Postdischarge Nausea and Vomiting

• Status: Active, not recruiting
• Trial end date: 2021-10-31
• Target enrollment: 0
• Participant gender: Female

Summary

Postoperative nausea and vomiting after general anesthesia is one of the common anesthetic complications. If the patient is discharged from the hospital after surgery, proper treatment may be delayed or impossible if nausea and vomiting occurred. Thus, it is necessary to prevent these symptoms beforehand. Patients who underwent day-surgery will be treated with prophylactic ramosetron orally disintegrating tablets to determine whether the frequency of nausea and vomiting is decreased when the patient returned home after discharge.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Ramosetron

Criteria

Inclusion Criteria:

• Patients who undergo day-surgery under general anesthesia and are discharged on the day of surgery

Exclusion Criteria:

• Pregnancy or breastfeeding

• Patients who are taking other serotonin receptor antagonists

• Patients who have galactose intolerance or Lapp lactase deficiency

• patients who have glucose-galactose malabsorption